Time and again, seemingly successful bank mergers have been rocked by revelations of poor anti-money-laundering compliance. Assessing the AML risk of a potential merger partner is extremely tricky, ...

Cetera agrees to pay $1.1 million fine after FINRA found the firm failed to properly monitor suspicious penny stock transactions ...

The industry regulator has sanctioned three broker-dealers in the Cetera network for weak controls around low-priced securities and customer reporting.

NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...

Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its lead acute myeloid leukemia (AML) asset into the clinic.